Sanara Medtech Inc stock is traded at $31.55, with a volume of 44,217. It is down -0.19% in the last 24 hours and down -9.86% over the past month. Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Previous Close:
$31.61
Open:
$31.52
24h Volume:
44,217
Relative Volume:
0.61
Market Cap:
$289.88M
Revenue:
$103.14M
Net Income/Loss:
-$5.82M
P/E Ratio:
-
EPS:
-$4.35
Net Cash Flow:
$2.14M
1W Performance:
-3.90%
1M Performance:
-9.86%
6M Performance:
+64.75%
1Y Performance:
+13.20%
1-Day Range:
$31.41$32.27
1-Week Range:
$29.05$33.32
52-Week Range:
$16.05$35.52
Sanara Medtech Inc Stock (SMTI) Company Profile
Name
Sanara Medtech IncSector
HealthcareIndustry
Medical Instruments & SuppliesPhone
817-529-2300Address
1200 SUMMIT AVE, FORT WORTH, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS